https://charts.traderzeitung.de/phases/US38246G1085
string(1455) "{"isin":"US38246G1085","name":"GoodRx Holdings Inc","stock_id_xnas":15155034,"stock_id_xnys":null,"generated_at":"2026-08-09 08:05:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.27,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.47,"close_at":"2026-08-05 23:41:00","complete":true,"perf_pct":6.1162}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.4,"close_at":"2026-08-06 15:29:00","complete":true,"perf_pct":-2.0173},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.727,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":9.6176},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.705,"close_at":"2026-08-06 23:21:00","complete":true,"perf_pct":-0.5903}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.675,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":-0.8097},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
GoodRx Holdings Aktie News & Nachrichten
Trading-Room

GoodRx Holdings Aktie News & Nachrichten

[WKN: A2QBX9 | Symbol: GDRX]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

GoodRx Holdings

TOP-5-Kursziele der Analysten am 11.06.25

Avidity Biosciences [US05370A1088]: Citigroup bekräftigt Buy-Rating und erhöht das Kursziel von 70...

  • ‹
  • 1
  • ›
GoodRx Holdings Nachrichtenticker öffnen
MT Newswires 07.08.2026 11:29 Uhr

Morgan Stanley passt das Kursziel für GoodRx von $3 auf $4 an und belässt die Einstufung auf Equalweight

05:28 AM EDT, 07.08.2026 (MT Newswires) -- GoodRx Holdings (GDRX) hat laut von FactSet befragten Analysten eine durchschnittliche Bewertung von Halten

MT Newswires 27.05.2026 16:14 Uhr

GoodRx startet neues monatliches Abonnement GoodRx Companion

10:14 AM EDT, 05/27/2026 (MT Newswires) -- GoodRx (GDRX) teilte am Mittwoch mit, dass es GoodRx Companion eingeführt hat, ein monatliches Abonnement f